- Article
18F-Fluoroazomycin Arabinoside (FAZA) PET/MR as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study
- Ur Metser,
- Andres Kohan,
- Catherine O’Brien,
- Rebecca K. S. Wong,
- Claudia Ortega,
- Patrick Veit-Haibach,
- Brandon Driscoll,
- Ivan Yeung and
- Adam Farag
Tumor hypoxia is a negative prognostic factor in many tumors and is predictive of metastatic spread and poor responsiveness to both chemotherapy and radiotherapy. Purpose: To assess the feasibility of using 18F-Fluoroazomycin arabinoside (FAZA) PET/M...

